The producer of Robitussin cough medicine is issuing a recall for various batches of their honey-containing products, as they may be contaminated and could be potentially harmful to individuals with compromised immune systems.

Haleon has issued a recall for eight batches of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult. These products were distributed to various stores and pharmacies. The Food and Drug Administration shared the company’s announcement on their website on Wednesday.

According to an email sent on Thursday, the company stated that their products could potentially have excessive amounts of yeast. While yeast is a natural element in honey, the amounts found by the company exceeded the permitted levels, as reported by Haleon.

Consumption of the infected syrup may lead to serious fungal infections that could pose a significant risk to individuals with compromised immune systems, such as those who have received organ transplants or have HIV. There are currently millions of people in the United States who have underlying conditions that hinder their body’s ability to combat infections.

According to the company, which is located in the United Kingdom with its U.S. headquarters in New Jersey, any infections caused by the products are unlikely to be severe for the majority of healthy individuals.

Haleon has stated that there have been no reports of injury or infection associated with their products. These products have expiration dates between October 2025 and June 2026.

Individuals who have utilized the product are advised to seek assistance from a healthcare professional if they believe they are encountering any issues connected to the product recall. They may also submit a report through the FDA’s web-based platform.

___

The Health and Science Department of the Associated Press is supported by the Science and Educational Media Group of the Howard Hughes Medical Institute. The AP is responsible for all content.